Literature DB >> 30976203

Prognostic value of Lin28A and Lin28B in various human malignancies: a systematic review and meta-analysis.

Jiayi Zhang1, Aiming Xu1, Chenkui Miao1, Jie Yang1, Min Gu1, Ninghong Song1.   

Abstract

BACKGROUND: The mammalian homologs of Lin-28, Lin28 (also called Lin28A) and Lin28B, are promising cancer biomarkers. This meta-analysis was performed to evaluate the prognostic values of Lin28A and Lin28B in multiple human malignancies.
METHODS: Systematic searches of the PubMed, Web of Science and Embase were used to identify relevant studies. Pooled hazard ratios (HRs) with 95% confidence intervals (CI) for overall survival (OS), recurrence-free survival (RFS), disease-free survival (DFS), or progression-free survival (PFS) were respectively calculated.
RESULTS: 3772 Lin28A-associated patients and 1730 Lin28B-related cases were ultimately enrolled in this meta-analysis. The elevated expression level of Lin28A was significantly associated with poor OS (HR = 1.60, P < 0.001) and poor RFS/DFS/PFS (HR = 1.62, P < 0.001) in patients with malignancies. Lin28B overexpression significantly correlated with unfavorable OS (HR = 1.72, P < 0.001) and RFS/DFS/PFS (HR = 2.35, P < 0.001) of human malignancies.
CONCLUSIONS: Lin28A and Lin28B possess significant prognostic values in various human malignancies. Overexpression of Lin28A or Lin28B suggests poor prognosis for cancer patients.

Entities:  

Keywords:  Biomarker; Human tumors; Lin-28; Meta-analysis; Prognosis

Year:  2019        PMID: 30976203      PMCID: PMC6444518          DOI: 10.1186/s12935-019-0788-z

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  43 in total

1.  LIN28B promotes colon cancer progression and metastasis.

Authors:  Catrina E King; Miriam Cuatrecasas; Antoni Castells; Antonia R Sepulveda; Ju-Seog Lee; Anil K Rustgi
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

2.  Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency.

Authors:  Anna Polesskaya; Sylvain Cuvellier; Irina Naguibneva; Arnaud Duquet; Eric G Moss; Annick Harel-Bellan
Journal:  Genes Dev       Date:  2007-05-01       Impact factor: 11.361

Review 3.  let-7 microRNAs in development, stem cells and cancer.

Authors:  Ingo Büssing; Frank J Slack; Helge Grosshans
Journal:  Trends Mol Med       Date:  2008-07-31       Impact factor: 11.951

4.  Immunohistochemical study identifying prognostic biomolecular markers in nasopharyngeal carcinoma treated by radiotherapy.

Authors:  Yeon-Joo Kim; Heounjeong Go; Hong-Gyun Wu; Yoon Kyung Jeon; Suk Won Park; Seung Hee Lee
Journal:  Head Neck       Date:  2010-11-04       Impact factor: 3.147

5.  Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma.

Authors:  Carolina Oliveira Rodini; Daniela Emi Suzuki; Najsla Saba-Silva; Andréa Cappellano; Jorge Estefano Santana de Souza; Sérgio Cavalheiro; Silvia Regina Caminada Toledo; Oswaldo Keith Okamoto
Journal:  J Neurooncol       Date:  2011-07-02       Impact factor: 4.130

6.  Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites.

Authors:  Eric G Moss; Lingjuan Tang
Journal:  Dev Biol       Date:  2003-06-15       Impact factor: 3.582

7.  Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II.

Authors:  Lingeng Lu; Dionyssios Katsaros; Khvaramze Shaverdashvili; Biyun Qian; Yixing Wu; Irene A Rigault de la Longrais; Mario Preti; Guido Menato; Herbert Yu
Journal:  Eur J Cancer       Date:  2009-05-26       Impact factor: 9.162

8.  The Lin28/let-7 axis regulates glucose metabolism.

Authors:  Hao Zhu; Ng Shyh-Chang; Ayellet V Segrè; Gen Shinoda; Samar P Shah; William S Einhorn; Ayumu Takeuchi; Jesse M Engreitz; John P Hagan; Michael G Kharas; Achia Urbach; James E Thornton; Robinson Triboulet; Richard I Gregory; David Altshuler; George Q Daley
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21

10.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279

View more
  6 in total

Review 1.  Complexity in regulating microRNA biogenesis in cancer.

Authors:  Pai-Sheng Chen; Shao-Chieh Lin; Shaw-Jenq Tsai
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-19

Review 2.  Drug delivery approaches for HuR-targeted therapy for lung cancer.

Authors:  Rajeswari Raguraman; Santny Shanmugarama; Meghna Mehta; Jo Elle Peterson; Yan D Zhao; Anupama Munshi; Rajagopal Ramesh
Journal:  Adv Drug Deliv Rev       Date:  2021-11-22       Impact factor: 15.470

3.  LIN28B Enhanced STAT3 Signaling Regulates Inflammatory Response and Chemotherapeutic Resistance in Cholangiocytes.

Authors:  Nattapong Puthdee; Supaporn Khramchantuk; Pattarin Nuwongsri
Journal:  Asian Pac J Cancer Prev       Date:  2021-11-01

4.  Effects of Let-7c on the processing of hepatitis B virus associated liver diseases.

Authors:  Like Zhang; Xia Jiang; Guiqi Wang; Tatsuo Kanda; Osamu Yokosuka; Congjie Zhai; Lei Zhang; Peng Liu; Zengren Zhao; Zhongxin Li
Journal:  Infect Agent Cancer       Date:  2022-09-03       Impact factor: 3.698

5.  Lin28A Regulates Stem-like Properties of Ovarian Cancer Cells by Enriching RAN and HSBP1 mRNA and Up-regulating its Protein Expression.

Authors:  Yancheng Zhong; Lanqin Cao; Haotian Ma; Qian Wang; Pingpin Wei; Juan Yang; Yuqing Mo; Lihua Cao; Cijun Shuai; Shuping Peng
Journal:  Int J Biol Sci       Date:  2020-04-15       Impact factor: 6.580

6.  LIN28B Polymorphisms Confer a Higher Postoperative Recurrence Risk in Reproductive-Age Women with Endometrial Polyps.

Authors:  Mei-Yin Lu; Xiao-Hong Li; Jia-Li Niu; Bin Liu
Journal:  Dis Markers       Date:  2022-02-27       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.